Company news
Fulgent Genetics, Inc. news in 2021
Fulgent Genetics, Inc.'s news releases, calls and decks from 2021, newest first.
Fulgent Genetics Confirms Ability to Detect Omicron Variant with RT-PCR Tests for COVID-19
November 30, 2021
Representatives of Fulgent Genetics to Participate in Upcoming Virtual Conferences
November 8, 2021
Fulgent Genetics Reports Third Quarter Financial Results
November 8, 2021
Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiver™ for Early Liver Cancer Detection
November 7, 2021
Helio Health and Fulgent Genetics to Present New Data on HelioLiver in Late-Breaking Presentation at The Liver Meeting® 2021
October 31, 2021
Fulgent Genetics Launches At-Home Neutralizing Antibody Test for COVID-19
October 26, 2021
Fulgent Genetics to Announce Third Quarter 2021 Financial Results on Tuesday November 9, 2021
October 24, 2021
Fulgent Genetics to Partner with Houston Health Department and Houston-Area Public Schools on Back-to-School COVID-19 Testing Program
September 22, 2021
Fulgent Genetics Reports Second Quarter Financial Results
August 8, 2021
Fulgent Genetics Announces Acquisition of CSI Laboratories
August 8, 2021
Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests
August 8, 2021
CORRECTING and REPLACING Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
July 25, 2021
Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech
May 9, 2021
Fulgent Genetics Welcomes Dr. Lawrence Weiss as Chief Medical Officer
May 5, 2021
Fulgent Genetics Reports Record First Quarter Financial Results
May 5, 2021
Fulgent Genetics to Announce First Quarter 2021 Financial Results on Thursday May 6, 2021
April 15, 2021
Fulgent Genetics Awarded Contract from CDC to Study Variants of COVID-19 Virus
March 14, 2021
Fulgent Genetics to Participate in the Oppenheimer 31st Annual Healthcare Conference
March 4, 2021
Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results
March 3, 2021
Fulgent Genetics to Announce Fourth Quarter and Full Year 2020 Financial Results on Thursday March 4, 2021
February 17, 2021
Fulgent Genetics to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference
January 5, 2021
Calls in 2021
Decks in 2021
- Q3 2021 Earnings Presentation
Earnings · 28 slides · Nov 9, 2021
- Q2 2021 Earnings Presentation
Earnings · 28 slides · Aug 9, 2021